These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 23797272)

  • 1. Aortic 18F-FDG PET/CT uptake pattern at 60 min (early) and 180 min (delayed) acquisition in a control population: a visual and semiquantitative comparative analysis.
    Martínez-Rodríguez I; Del Castillo-Matos R; Quirce R; Banzo I; Jiménez-Bonilla J; Martínez-Amador N; Ibáñez-Bravo S; Lavado-Pérez C; Bravo-Ferrer Z; Carril JM
    Nucl Med Commun; 2013 Sep; 34(9):926-30. PubMed ID: 23797272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural history of atherosclerotic disease progression as assessed by (18)F-FDG PET/CT.
    Hetterich H; Rominger A; Walter L; Habs M; Volpers S; Hacker M; Reiser MF; Bartenstein P; Saam T
    Int J Cardiovasc Imaging; 2016 Jan; 32(1):49-59. PubMed ID: 25898891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of early (60 min) and delayed (180 min) acquisition of 18F-FDG PET/CT in large vessel vasculitis.
    Martínez-Rodríguez I; del Castillo-Matos R; Quirce R; Jiménez-Bonilla J; de Arcocha-Torres M; Ortega-Nava F; Rubio-Vassallo A; Martínez Amador N; Ibáñez Bravo S; Carril JM
    Rev Esp Med Nucl Imagen Mol; 2013; 32(4):222-6. PubMed ID: 23688731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantifying [¹⁸F]fluorodeoxyglucose uptake in the arterial wall: the effects of dual time-point imaging and partial volume effect correction.
    Blomberg BA; Bashyam A; Ramachandran A; Gholami S; Houshmand S; Salavati A; Werner T; Zaidi H; Alavi A
    Eur J Nucl Med Mol Imaging; 2015 Aug; 42(9):1414-22. PubMed ID: 25962589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed time-point 18F-FDG PET CT imaging enhances assessment of atherosclerotic plaque inflammation.
    Blomberg BA; Akers SR; Saboury B; Mehta NN; Cheng G; Torigian DA; Lim E; Del Bello C; Werner TJ; Alavi A
    Nucl Med Commun; 2013 Sep; 34(9):860-7. PubMed ID: 23799532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of aortitis by semiquantitative analysis of 180-min 18F-FDG PET/CT acquisition images.
    Martínez-Rodríguez I; Martínez-Amador N; Banzo I; Quirce R; Jiménez-Bonilla J; De Arcocha-Torres M; Ibáñez-Bravo S; Lavado-Pérez C; Bravo-Ferrer Z; Blanco R; González-Gay MA; Carril JM
    Eur J Nucl Med Mol Imaging; 2014 Dec; 41(12):2319-24. PubMed ID: 25056634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A positron emission tomography/computed tomography (PET/CT) evaluation of asymptomatic abdominal aortic aneurysms: another point of view.
    Palombo D; Morbelli S; Spinella G; Pane B; Marini C; Rousas N; Massollo M; Cittadini G; Camellino D; Sambuceti G
    Ann Vasc Surg; 2012 May; 26(4):491-9. PubMed ID: 22197524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modest utility of quantitative measures in (18)F-fluorodeoxyglucose positron emission tomography scanning for the diagnosis of aortic prosthetic graft infection.
    Saleem BR; Berger P; Vaartjes I; de Keizer B; Vonken EJ; Slart RH; de Borst GJ; Zeebregts CJ
    J Vasc Surg; 2015 Apr; 61(4):965-71. PubMed ID: 25498161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular inflammation imaging with 18F-FDG PET/CT: when to image?
    Menezes LJ; Kotze CW; Hutton BF; Endozo R; Dickson JC; Cullum I; Yusuf SW; Ell PJ; Groves AM
    J Nucl Med; 2009 Jun; 50(6):854-7. PubMed ID: 19443587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifactorial relationship between 18F-fluoro-deoxy-glucose positron emission tomography signaling and biomechanical properties in unruptured aortic aneurysms.
    Nchimi A; Cheramy-Bien JP; Gasser TC; Namur G; Gomez P; Seidel L; Albert A; Defraigne JO; Labropoulos N; Sakalihasan N
    Circ Cardiovasc Imaging; 2014 Jan; 7(1):82-91. PubMed ID: 24190906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normal variants of bowel FDG uptake in dual-time-point PET/CT imaging.
    Toriihara A; Yoshida K; Umehara I; Shibuya H
    Ann Nucl Med; 2011 Apr; 25(3):173-8. PubMed ID: 21088936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing 18F-FDG PET/CT imaging of vessel wall inflammation: the impact of 18F-FDG circulation time, injected dose, uptake parameters, and fasting blood glucose levels.
    Bucerius J; Mani V; Moncrieff C; Machac J; Fuster V; Farkouh ME; Tawakol A; Rudd JH; Fayad ZA
    Eur J Nucl Med Mol Imaging; 2014 Feb; 41(2):369-83. PubMed ID: 24271038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18F-FDG uptake in main arterial branches of patients with large vessel vasculitis: visual and semiquantitative analysis.
    Castellani M; Vadrucci M; Florimonte L; Caronni M; Benti R; Bonara P
    Ann Nucl Med; 2016 Jul; 30(6):409-20. PubMed ID: 27068039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of inflammation within rabbit atherosclerotic plaques using the macrophage-specific CT contrast agent N1177: a comparison with 18F-FDG PET/CT and histology.
    Hyafil F; Cornily JC; Rudd JH; Machac J; Feldman LJ; Fayad ZA
    J Nucl Med; 2009 Jun; 50(6):959-65. PubMed ID: 19443582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
    Schaefferkoetter JD; Carlson ER; Heidel RE
    J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions.
    Eiber M; Takei T; Souvatzoglou M; Mayerhoefer ME; Fürst S; Gaertner FC; Loeffelbein DJ; Rummeny EJ; Ziegler SI; Schwaiger M; Beer AJ
    J Nucl Med; 2014 Feb; 55(2):191-7. PubMed ID: 24309383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography cannot replace bone marrow biopsy in diffuse large B-cell lymphoma.
    Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Nievelstein RA; de Klerk JM
    Am J Hematol; 2014 Jul; 89(7):726-31. PubMed ID: 24711255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Semiquantitative Analysis of the Biodistribution of the Combined ¹⁸F-NaF and ¹⁸F-FDG Administration for PET/CT Imaging.
    Minamimoto R; Mosci C; Jamali M; Barkhodari A; Habte F; Jackson T; Mittra E; Gambhir SS; Iagaru A
    J Nucl Med; 2015 May; 56(5):688-94. PubMed ID: 25840978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of age and cardiovascular risk factors on (18)F-FDG PET/CT quantification of atherosclerosis in the aorta and peripheral arteries.
    Pasha AK; Moghbel M; Saboury B; Gharavi MH; Blomberg BA; Torigian DA; Kwee TC; Basu S; Mohler Iii ER; Alavi A
    Hell J Nucl Med; 2015; 18(1):5-10. PubMed ID: 25679072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards an optimal semiquantitative approach in giant cell arteritis: an (18)F-FDG PET/CT case-control study.
    Besson FL; de Boysson H; Parienti JJ; Bouvard G; Bienvenu B; Agostini D
    Eur J Nucl Med Mol Imaging; 2014 Jan; 41(1):155-66. PubMed ID: 24008434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.